Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 62 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,593 followers.

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer https://t.co/LvMTAyWCLt

16 Feb 2021

Reply Repost Favourite

Nice review over the research perfomed on the role of immunotherapy on early stage NSCLC. As a reviewer of the manuscript, I am happy that is now available in @FrontiersIn for all the scientific comunity. https://t.co/JJ9HtjBDji https://t.co/e26ButZSHF

09 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.